Ronnett Seldon

Ronnett Seldon

Auto-generated profile, based on publicly available information

Ronnett Seldon

Aerobiology and TB Research Unit, Desmond Tutu Health Foundation

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2021 in Bioorganic Chemistry
Verified
Journal Article
Closed access
CEChané Erasmus
Chané Erasmus
JAJanine Aucamp
Janine Aucamp
FSFrans Smit
Frans Smit
RSRonnett Seldon
Ronnett Seldon
AJAudrey Jordaan
Audrey Jordaan
DNDavid N'da
David N'da

11 June 2021 in Advances in Pharmacological and Pharmaceutical Sciences
Verified
Journal Article
Open access
PDF file
EKErika Kapp
Erika Kapp
JJJacques Joubert
Jacques Joubert
SSSamantha Sampson
Samantha Sampson
DWDigby Warner
Digby Warner
RSRonnett Seldon
Ronnett Seldon
SMSarel Malan
Sarel Malan
Mycobacterium tuberculosis has developed extensive resistance to numerous antimycobacterial agents used in the treatment of tuberculosis. Insufficient intracellular accumulation of active moieties allows for selective survival of mycobacteria with drug resistance mutations and accordingly promotes the development of microbial drug resistance. Discovery of compounds with new mechanisms of action and physicochemical properties that promote intracellular accumulation, or compounds that act synergistically with other antimycobacterial drugs, has the potential to reduce and prevent further drug resistance. To this end, antimycobacterial activity, mechanism of action, and synergism in combination therapy were investigated for a series of polycyclic amine derivatives. Compound selection was based on the presence of moieties with possible antimycobacterial activity, the inclusion of bulky lipophilic carriers to promote intracellular accumulation, and previously demonstrated bioactivity that potentially support inhibition of efflux pump activity. The most potent antimycobacterial demonstrated a minimum inhibitory concentration (MIC99) of 9.6μM against Mycobacterium tuberculosis H37Rv. Genotoxicity and inhibition of the cytochrome bc1 respiratory complex were excluded as mechanisms of action for all compounds. Inhibition of cell wall synthesis was identified as a likely mechanism of action for the two most active compounds (14 and 15). Compounds 5 and 6 demonstrated synergistic activity with the known Rv1258c efflux pump substrate, spectinomycin, pointing to possible efflux pump inhibition. For this series, the nature of the side chain, rather than the type of polycyclic carrier, seems to play a determining role in the antimycobacterial activity and cytotoxicity of the compounds. Contrariwise, the nature of the polycyclic carrier, particularly the azapentacycloundecane cage, appears to promote synergistic activity. Results point to the possibility of combining an azapentacycloundecane carrier with a side chain that promotes antimycobacterial activity to develop dual acting molecules for the treatment of Mycobacterium tuberculosis.

27 July 2022 in Infection Control & Hospital Epidemiology
Verified
Journal Article
Open access
PDF file
KMKeren Middelkoop
Keren Middelkoop
AKAnastasia S. Koch
Anastasia S. Koch
ZHZeenat Hoosen
Zeenat Hoosen
WBWayne Bryden
Wayne Bryden
CCCharles Call
Charles Call
JAJason R. Andrews
Jason R. Andrews
Objective:Novel approaches are needed to understand and disrupt Mycobacterium tuberculosis transmission. In this proof-of-concept study, we investigated the use of environmental air samplings to detect and quantify M. tuberculosis in different clinic settings in a high-burden area.Design:Cross-sectional, environmental sampling.Setting:Primary-care clinic.Methods:A portable, high-flow dry filter unit (DFU) was used to draw air through polyester felt filters for 2 hours. Samples were collected in the waiting area and TB room of a primary care clinic. Controls included sterile filters placed directly into collection tubes at the DFU sampling site, and filter samplings performed outdoors. DNA was extracted from the filters, and droplet digital polymerase chain reaction (ddPCR) was used to quantify M. tuberculosis DNA copies. Carbon dioxide (CO2) data loggers captured CO2 concentrations in the sampled areas.Results:The median sampling time was 123 minutes (interquartile range [IQR], 121–126). A median of 121 (IQR, 35–243) M. tuberculosis DNA copies were obtained from 74 clinic samplings, compared to a median of 3 (IQR, 1–33; P < .001) obtained from 47 controls. At a threshold of 320 DNA copies, specificity was 100%, and 18% of clinic samples would be classified as positive.Conclusions:This proof-of-concept study suggests that the potential for airborne M. tuberculosis detection based on M. tuberculosis DNA copy yield to enable the identification of high-risk transmission locations. Further optimization of the M. tuberculosis extraction technique and ddPCR data analysis would improve detection and enable robust interpretation of these data.

16 May 2022 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
CRCelestine Raidron
Celestine Raidron
AJAudrey Jordaan
Audrey Jordaan
RSRonnett Seldon
Ronnett Seldon
DWDigby Warner
Digby Warner
CKCarmen de Kock
Carmen de Kock
RHRenate Hazel Hans
Renate Hazel Hans

1 March 2020 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
MMMeloddy Hlatini Manyeruke
Meloddy Hlatini Manyeruke
TTThendamudzimu Tshiwawa
Thendamudzimu Tshiwawa
HHHeinrich Hoppe
Heinrich Hoppe
MIMichelle Isaacs
Michelle Isaacs
RSRonnett Seldon
Ronnett Seldon
PKPerry T. Kaye
Perry T. Kaye

3 April 2024 in medRxiv
Verified
Preprint
Open access
PDF file
RDRyan Dinkele
Ryan Dinkele
SGSophia Gessner
Sophia Gessner
BPBenjamin Patterson
Benjamin Patterson
AMAndrea McKerry
Andrea McKerry
ZHZeenat Hoosen
Zeenat Hoosen
RWRobin Wood
Robin Wood
Pioneering studies linking symptomatic disease and cough-mediated release of Mycobacterium tuberculosis ( Mtb ) established the infectious origin of tuberculosis (TB), simultaneously informing the pervasive notion that pathology is a prerequisite for Mtb transmission. Our prior work has challenged this assumption: by sampling TB clinic attendees, we detected equivalent release of Mtb -containing bioaerosols by confirmed TB patients and individuals not receiving a TB diagnosis, and we demonstrated a time-dependent reduction in Mtb bioaerosol positivity during six-months’ follow-up, irrespective of anti-TB chemotherapy. Now, by extending bioaerosol sampling to a randomly selected community cohort, we show that Mtb release is common in a TB-endemic setting: of 89 participants, 79.8% (71/89) produced Mtb bioaerosols independently of QuantiFERON-TB Gold status, a standard test for Mtb infection; moreover, during two-months’ longitudinal sampling, only 2% (1/50) were serially Mtb bioaerosol negative. These results necessitate a reframing of the prevailing paradigm of Mtb transmission and infection, and may explain the current inability to elucidate Mtb transmission networks in TB-endemic regions. Summary: Elucidating chains of Mycobacterium tuberculosis transmission is limited by a dependence on linking sputum-positive tuberculosis cases. Here, we report persistent M. tuberculosis bioaerosol release in the majority of a randomly selected community cohort. The contribution to tuberculosis transmission is unknown.